Plus Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.28 | -$0.88 | -$1.09 |
| Q2 2024 | 1 | -$0.62 | -$0.43 | -$0.53 |
| Q3 2024 | 1 | -$0.66 | -$0.45 | -$0.56 |
| Q4 2024 | 2 | -$0.46 | -$0.28 | -$0.38 |
| Q1 2025 | 2 | -$0.31 | -$0.25 | -$0.28 |
| Q2 2025 | 1 | -$0.34 | -$0.23 | -$0.29 |
| Q3 2025 | 1 | -$0.37 | -$0.25 | -$0.32 |
| Q4 2025 | 1 | -$0.50 | -$0.34 | -$0.42 |
Plus Therapeutics, Inc. Earnings Date And Information
Plus Therapeutics, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.46 earnings per share for the quarter, missing analysts' consensus estimates of $-0.46 by $0. The company had revenue of 0 for the quarter and had revenue of 4.91 M for the year. Plus Therapeutics, Inc. has generated $-4 earnings per share over the last year ($-4.24 diluted earnings per share) and currently has a price-to-earnings ratio of -0.72. Plus Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
Plus Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.46 | -$0.37 | 0.09 | $1.47 M | $0 |
| 08/14/2024 | Q2 2024 | -$0.53 | -$0.45 | 0.08 | $1.70 M | $1.28 M |
| 03/29/2024 | Q1 2024 | -$0.75 | $1.68 M | |||
| 12/30/2023 | Q4 2023 | -$0.84 | $1.31 M | |||
| 10/31/2023 | Q3 2023 | -$0.58 | -$1.00 | -0.42 | $1.86 M | $1.24 M |
| 08/14/2023 | Q2 2023 | -$1.91 | -$0.59 | 1.32 | $1.05 M | $1.85 M |
| 04/20/2023 | Q1 2023 | -$2.10 | -$2.07 | 0.03 | $506,000 | |
| 02/23/2023 | Q4 2022 | -$2.25 | -$2.56 | -0.31 | $224,000 | |
| 10/20/2022 | Q3 2022 | -$3.15 | -$2.85 | 0.3 | $300,000 | $0 |
| 07/21/2022 | Q2 2022 | -$2.70 | -$3.67 | -0.97 | $0 | |
| 04/21/2022 | Q1 2022 | -$2.55 | -$3.00 | -0.45 | $0 | |
| 02/24/2022 | Q4 2021 | -$3.45 | -$4.05 | -0.6 | $0 | |
| 10/21/2021 | Q3 2021 | -$3.15 | -$4.21 | -1.06 | $0 | |
| 07/22/2021 | Q2 2021 | -$3.45 | -$3.72 | -0.27 | $0 | |
| 04/22/2021 | Q1 2021 | -$4.65 | -$4.93 | -0.28 | $0 | |
| 02/22/2021 | Q4 2020 | -$4.95 | -$10.02 | -5.07 | $0 | |
| 10/22/2020 | Q3 2020 | -$0.55 | -$5.89 | -5.34 | $0 | |
| 08/10/2020 | Q2 2020 | -$0.75 | -$6.81 | -6.06 | $185,000 | |
| 05/14/2020 | Q1 2020 | -$0.75 | -$4.20 | -3.45 | $118,000 | |
| 03/30/2020 | Q4 2019 | $3.42 | $1.19 M |
Plus Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Plus Therapeutics, Inc.'s earnings date?
Plus Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
-
How can I listen to Plus Therapeutics, Inc.'s earnings conference call?
The conference call for Plus Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Plus Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Plus Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Plus Therapeutics, Inc. generate each year?
Plus Therapeutics, Inc. (:PSTV) has a recorded annual revenue of $4.91 M.
-
How much profit does Plus Therapeutics, Inc. generate each year?
Plus Therapeutics, Inc. (:PSTV) has a recorded net income of $4.91 M. Plus Therapeutics, Inc. has generated $-4.24 earnings per share over the last four quarters.
-
What is Plus Therapeutics, Inc.'s price-to-earnings ratio?
Plus Therapeutics, Inc. (:PSTV) has a price-to-earnings ratio of -0.72 and price/earnings-to-growth ratio is -0.03.
